earnings
confidence high
sentiment positive
materiality 0.70
Artivion Q1 revenue $99M (+2% GAAP), net loss $0.5M; raises FY 2025 guidance
ARTIVION, INC.
2025-Q1 EPS reported
-$0.01
revenue$98,978,000
- Revenue $99.0M, up 2% GAAP (4% constant currency); net loss $(0.5)M vs net income $7.5M in Q1 2024.
- Non-GAAP net income $2.5M ($0.06 diluted); adjusted EBITDA $17.5M (+1% YoY).
- Product growth: stent grafts +14%, On-X +10%, BioGlue +7%; preservation services -23% from cyber backlog.
- FY 2025 guidance raised: revenue $423-435M (11-14% constant currency growth); adj. EBITDA $84-91M.
- Positive 30-day NEXUS data (63% MAE reduction); PMA submitted for AMDS Hybrid Prosthesis to FDA.